SCHEMBL20161080

SCHEMBL20161080

Cc1cc(C)cc(-c2c(-c3ccccc3)c(-c3ccccc3)c(-c3cc(C)cc(C)c3)c(-c3ccc(-n4c5ccccc5c5cc6oc7ccccc7c6cc54)cc3)c2-c2ccc(B3OC(C)(C)C(C)(C)O3)cc2)c1

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LIPG Q9Y5X9 5/20 0.40
LPL P06858 4/20 0.40
CSF1R P07333 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20161079 0.87 LIPG (0.48) LIPGLPL
SCHEMBL20161021 0.84 AHR (0.38)
SCHEMBL24537846 0.82 LIPG (0.43) LIPGLPL
SCHEMBL22143468 0.80 LIPG (0.55) LIPGLPL
SCHEMBL17177951 0.79 LIPG (0.37) LIPGLPL
SCHEMBL20161170 0.78 LIPG (0.45) LIPGLPL
SCHEMBL21479668 0.78 LPL (0.34) LIPGLPL
SCHEMBL20161077 0.77 LIPG (0.48) LIPGLPL
SCHEMBL17245952 0.77 KDM4E (0.46)
SCHEMBL15451817 0.77 KDM4E (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2023-11-02 US disclosed
EP-4271163-A2 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP Merck Patent GmbH (DE) 2023-11-01 EP disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
US-11711976-B2 Compounds with an acceptor and a donor group MERCK PATENT GMBH (DE) 2023-07-25 US disclosed
US-20200203624-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2020-06-25 US disclosed
WO-2018087346-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP MERCK PATENT GMBH (DE) 2018-05-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11711976-B2 Compounds with an acceptor and a donor group NQO1, ICMT, NUDT1 LIPG 1743/4885LPL 3991/4885CSF1R 4268/4885
US-20200203624-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 LIPG 1743/4885LPL 3991/4885CSF1R 4268/4885
US-20230354701-A1 COMPOUNDS WITH AN ACCEPTOR AND A DONOR GROUP NQO1, ICMT, NUDT1 LIPG 1743/4885LPL 3991/4885CSF1R 4268/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.